Literature DB >> 18463915

Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites.

Hyunchul Rhim1, Hyo K Lim.   

Abstract

Ultrasound (US)-guided percutanoeus radiofrequency (RF) ablation is difficult to perform for treating a hepatic tumor abutting the diaphragm due to a poor sonic window and high risk of diaphragmatic thermal injury. RF ablation with assistance of the use of artificial ascites is a simple and safe technique for treating a hepatic dome tumor abutting the diaphragm. One can improve the sonic window and separate the RF ablation zone from the diaphragm by downward displacement of the liver with the use of a simple and inexpensive technique. Dextrose water solution is an ideal fluid due to its nonionic nature. Complications related to the use of artificial ascites including hemoperitoneum are rare. Peritoneal adhesion and tumor location in the bare area are the limitations for the application of this technique.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18463915     DOI: 10.1007/s00261-008-9408-4

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  20 in total

1.  Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism.

Authors:  Byung Seup Kim; Tae Ik Eom; Kyung Ho Kang; Sung Jun Park
Journal:  J Med Ultrason (2001)       Date:  2013-09-20       Impact factor: 1.314

2.  Artificial pleural effusion in percutaneous microwave ablation of hepatic tumors near the diaphragm under the guidance of ultrasound.

Authors:  Gang Wang; Yao Sun; Lin Cong; Xuehong Jing; Jing Yu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.

Authors:  Ji Hye Min; Min Woo Lee; Dong Ik Cha; Yong Hwan Jeon; Sung Wook Shin; Sung Ki Cho; Hyunchul Rhim; Hyo K Lim
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

Review 4.  Image-guided percutaneous ablation of hepatic malignancies.

Authors:  Gretchen Foltz
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

5.  Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.

Authors:  Inyoung Song; Hyunchul Rhim; Hyo K Lim; Young-Sun Kim; Dongil Choi
Journal:  Eur Radiol       Date:  2009-06-26       Impact factor: 5.315

6.  Artificial ascites using the guidewire technique during microwave ablation in the liver dome: technique and analysis of fluid repartition.

Authors:  Louis Delmas; Guillaume Koch; Roberto Luigi Cazzato; Julia Weiss; Pierre Auloge; Danoob Dalili; Pierre de Marini; Afshin Gangi; Julien Garnon
Journal:  Abdom Radiol (NY)       Date:  2021-04-12

7.  Combined transarterial chemoembolization and radiofrequency ablation for subphrenic versus nonsubphrenic hepatocellular carcinoma: a propensity score matched study.

Authors:  Jun Gon Kim; Sung Ki Cho; Dongho Hyun; Sung Wook Shin; Kwang Bo Park; Hong Suk Park; Sung Wook Choo; Young Soo Do; Sook-Young Woo; Sun-Young Baek
Journal:  Abdom Radiol (NY)       Date:  2021-09-28

8.  Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma.

Authors:  Min Hwan Kwak; Min Woo Lee; Seong Eun Ko; Hyunchul Rhim; Tae Wook Kang; Kyoung Doo Song; Jong Man Kim; Gyu-Seong Choi
Journal:  Ultrasonography       Date:  2022-02-09

9.  Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.

Authors:  Hideomi Yamashita; Hiroshi Onishi; Naoya Murakami; Yasuo Matsumoto; Yukinori Matsuo; Takuma Nomiya; Keiichi Nakagawa
Journal:  J Radiat Res       Date:  2015-02-16       Impact factor: 2.724

10.  Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations.

Authors:  Dong Ik Cha; Min Woo Lee; Hyunchul Rhim; Dongil Choi; Young-sun Kim; Hyo K Lim
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.